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We developed a highly sensitive and specific LAMP assay for Escherichia coli. It does not require DNA
extraction and can detect as few as 10 copies. It detected all 36 of 36 E. coli isolates and all 22 urine samples
(out of 89 samples tested) that had E. coli. This assay is rapid, low in cost, and simple to perform.
Escherichia coli can cause infections of a variety of extraint-
estinal sites such as the urinary tract, meninges, and blood-
stream (3, 5, 8, 10–12, 21). Diagnosis of most extraintestinal E.
coli (ExPEC) infections requires bacterial culture, requiring 1
to 2 days of incubation, and subsequent confirmatory testing
(6, 17). Guidance as to the presence or absence of an ExPEC
infection at initial presentation could be useful for a patient,
especially when attempting to reduce excessive use of antibi-
otics. Although conventional DNA amplification using PCR
can provide fast results, it is not widely used partly because it
requires considerable skill and expensive equipment. Recently,
loop-mediated isothermal amplification (LAMP), a rapid tech-
nique for amplifying DNA has been reported (14, 15). It re-
quires incubation at a constant temperature (60 to 66°C for 30
to 60 min) and eliminates the need for specialized equipment
or expertise. We report here the development and character-
ization of a LAMP assay to detect urinary E. coli.
Three sets of primers (outer, loop, and inner) were required
for the E. coli LAMP assay that were designed by analyzing a
conserved region of the E. coli malB gene with Primer Explorer
version 3 software (http://primerexplorer.jp/elamp3.0.0/index
.html) (Fig. 1). This gene is conserved across diverse lineages
of E. coli and is not shared by other gram-negative bacteria
except Shigella spp., based on BLAST analysis (http://www.ncbi
.nlm.nih.gov/BLAST/) (18). We considered this region to be
appropriate because of its conservation, as well as the rarity of
Shigella as a cause of extraintestinal infections.
The LAMP reaction was conducted using methods de-
scribed previously, with minor modifications (14, 15). The final
LAMP reaction (total, 25 l) contained the three primer pairs
in the following concentrations: 0.2 M outer primers, 0.8 M
loop primers, and 1.6 M inner primers. The reaction mix also
contained 2.5 l of 10 Bst DNA polymerase reaction buffer
[1 containing 20 mM Tris-HCl, 10 mM KCl, 10 mM
(NH2)SO4, 2 mM MgSO4, 0.1% Triton X-100], 1 l of an
8-U/l concentration of Bst DNA polymerase (New England
Biolabs, Inc., MA), 2 mM MgSO4 (2 l), 5 l of betaine
(Sigma-Aldrich, St. Louis, MO), and 5 l of sample. We gen-
erated and quantified a plasmid containing the target E. coli
sequence to determine the sensitivity of the LAMP assay. The
target sequence in E. coli was amplified by PCR using the
primers F3 and B3 of the LAMP assay and cloned by using a
StrataClone PCR cloning kit (Stratagene, La Jolla, CA). The
copy number of the solution containing the E. coli clone was
determined by UV spectrophotometry (2). The analytical sen-
sitivity of LAMP was determined by using 10-fold serial dilu-
tions of the E. coli clone.
The LAMP reaction was performed in a heating block (Lab-
Line, Iowa). For comparison, it was also performed using a
conventional thermal cycler (Bio-Rad, California), and both
machines performed equally well. The cost per reaction was ca.
50¢ (U.S. currency).
A positive E. coli LAMP reaction typically required incuba-
tion for 60 min at 66°C to produce a ladder pattern on agarose
gel (Fig. 2i). The E. coli LAMP products from several of the
bands in the gel were excised and sequenced. The amplicons
matched the E. coli malB gene segment spanned by F3/B3
primers. The E. coli LAMP products were also detected with-
out electrophoresis using ambient light after the addition of a
number of DNA dyes to the reaction tube. These dyes included
propidium iodide, ethidium bromide, methylene blue, acridine
orange, and Sybr green. Of the various dyes, Sybr green (1:10
* Corresponding author. Mailing address: Department of Pediatrics,
Children’s Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA
15213. Phone: (412) 692-5182. Fax: (412) 692-7443. E-mail: abhay.vats
@chp.edu.
† Present address: Hospital for Children and Adolescents, Univer-
sity of Helsinki, PB 281, 00029 Helsinki, Finland.
 Published ahead of print on 11 June 2008.
2800
 o
n
 January 30, 2017 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
dilution of a 10,000 stock solution) and propidium iodide
(1:10 dilution of 10-mg/ml stock solution) produced the best
visual discrimination. For both the dyes, 1 l of the diluted dye
was added to 25 l of the reaction mix to develop the color
reaction (Fig.2ii). UV transillumination of the reaction mix
containing the DNA dye improved the differentiation further.
The specificity of the assay was evaluated by testing eight
gram-negative bacteria (Acinetobacter spp., Citrobacter freun-
dii, Enterobacter cloacae, Haemophilus influenzae, Klebsiella
pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and
Serratia marcescens) and six gram-positive bacteria (Enterococ-
cus faecalis, Staphylococcus aureus, Staphylococcus epidermidis,
Streptococcus pneumoniae, Streptococcus pyogenes, and Strepto-
coccus viridians). No ladder pattern was seen with any of the
other non-E. coli bacteria or with the negative “no-target”
control (Fig. 2i). The sensitivity of E. coli LAMP was found to
be approximately 10 copies per reaction when an incubation
period of 60 min was used. Larger copy numbers required
shorter incubation times (as low as 15 to 20 min for1,000,000
copies).
We further tested a range of E. coli isolates by this assay. A
total of 36 isolates of E. coli from unique patients (n  23) or
the Escherichia coli Reference (ECOR) Collection (n  13)
were tested. ECOR (established in 1984) contains 72 strains
and five phylotypes (16). A LAMP assay was performed on an
aliquot of bacterial solution without extraction of DNA. It was
able to detect all of the 36 E. coli isolates (Table 1). Finally, 89
fresh urine samples were tested by LAMP assay, and the re-
sults were compared to cultured urine samples obtained from
microbiology laboratories of the Children’s Hospital of Pitts-
burgh and the All India Institute of Medical Sciences from
patients suspected with urinary tract infections (UTI). The
culture was considered “positive” if there was growth of indi-
vidual bacteria in a concentration of 100,000 colonies/ml.
Growth of multiple bacteria was considered contamination.
The samples were stored at 4°C after plating of urine and were
analyzed by LAMP assay within 1 to 3 days of collection. Initial
LAMP testing, performed on three known E. coli-positive
urine samples, showed positive results both with and without
DNA extraction using a QIAmp DNA Mini-Kit (Qiagen, Cal-
ifornia). Subsequent tests were performed on unextracted
urine, i.e., 5 l of unprocessed urine was directly added to the
LAMP reaction mix, followed by incubation for 60 min at 66°C.
Of the 89 urine samples, 22 were positive for E. coli, all of
which tested positive by the LAMP assay. In addition, 36 sam-
ples had no bacterial growth, and the LAMP assay results were
negative in all of these samples. Finally, in 31 samples, organ-
isms other than E. coli grew, including 13 samples that pro-
FIG. 1. LAMP primers. (i) Location of the LAMP primers in the E. coli malB gene. This sequence represents positions 3204 to 3407 in the E.
coli GenBank sequence (GDB J01648). The F2 and Loop F primers overlap by one base, depicted by “*” and an italic “T”. Also, two of the reverse
primers, Loop B and B2, are contiguous and have no bases separating them, and the juncture is marked by “*” and an arrow. (ii) Sequences for
the LAMP primers. The F1c and B2c sequences are the reverse complements of the F1 and B2 regions shown in Fig. 1 and are underlined.
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duced 1 bacterial species. In 29 of these 31 samples, the
LAMP assay was negative. Two non-E. coli samples that had
tested positive by the LAMP assay had grown multiple organ-
isms and probably had E. coli as one of the contaminants
(Tables 2 and 3).
We describe here a new, rapid, and economical assay to
detect E. coli in human urine in 1 h (or less), which makes this
assay amenable for point-of-care or outpatient settings. There
are several advantages of the LAMP over PCR, the conven-
tional method for DNA amplification. This assay only needs a
heating block and obviates the need for a thermal cycler. Also,
DNA extraction is not required for LAMP. In contrast, un-
processed urine normally requires DNA extraction for PCR,
since urinary urea can inhibit PCR at concentrations of 50
mM and the normal concentration of urea in adult urine is
330 mM (1, 4, 9, 20). Hence, the LAMP assay, by eliminating
the step of DNA extraction, is more “user friendly” than PCR.
We focused on urine as the analyte for the present study and
obtained consistent results for all of the culture-positive sam-
ples. Although we did not test other biological fluids (e.g.,
blood, cerebrospinal fluid, etc.) it is likely, based on our recent
studies on BK virus LAMP, that E. coli LAMP would perform
well with these types of specimens (2).
Another advantage of this assay is that identification of a
positive reaction does not require any special processing or
electrophoresis. It could be detected by looking for a color
change of the reaction mix in ambient light, when a DNA-
binding dye is used. This visualization can be further enhanced
by UV transillumination. We also showed that a simple chem-
ical such as propidium iodide can be used for detecting a
positive reaction. To our knowledge, this is the first report of
using propidium iodide to visualize LAMP products. Pro-
FIG. 2. LAMP assay reactions. (i) A gel image showing LAMP products from E. coli and other bacteria. The lane numbers correspond to the
following specimens. Lanes: 1, E. coli; 2, 100-bp ladder; 3, Proteus mirabilis; 4, Pseudomonas aeruginosa; 5, Enterobacter faecalis; 6, Staphylococcus
aureus; 7, Streptococcus pyogenes; 8, Streptococcus pneumoniae; 9, Streptococcus viridans; 10, no target control. (ii) Visualization of LAMP products
by inspection. (A) Propidium iodide without UV illumination. The color changes from a deep red-orange in the negative reaction to a light (almost
clear) pink in the positive reaction. (B) Propidium iodide with UV illumination showing bright transillumination in the positive reaction. (C) Sybr
green without UV illumination. The color changes from orange in the negative to green in the positive reaction. (D) Sybr green with UV
illumination showing bright transillumination in the positive reaction.
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pidium iodide is less expensive, does not require freezing for
storage, and is more easily available in developing countries,
such as India, than is Sybr green. In theory, a deep color of the
urine (bilirubin, myoglobin, or other chromogens) could affect
the color of the final LAMP products and interfere with the
assay results, but we did not see this effect in the range of
samples of urine tested that had minor color variation (from
clear to pale yellow).
Our assay was able to detect a large number of strains
studied with a very high sensitivity. Indeed, the ability to detect
10 copies per reaction may be considered to be “too sensitive”
for use as a clinical assay for UTI diagnostics. However, the
assay’s sensitivity can be lowered to match the conventionally
accepted cutoff of 100,000 copies/ml for urine if a shorter
incubation time is used (i.e., 30 to 40 min versus 60 min). It is
likely that different levels of sensitivity may be required for
different biological fluids. For example, it may be necessary to
have a high sensitivity for blood and CSF versus a lower sen-
sitivity for urine for the assays to be clinically meaningful. Also,
an ability to detect a lower copy number may be important in
partially treated infections (after empirical antibiotic doses),
where the organisms are reduced in number or not culturable
but the DNA is still detectable.
Although LAMP assays for various specific E. coli strains
have been reported, these studies were designed to detect
virulence loci or markers of specific strains, such as vero-
toxin (7, 19, 22). However, for detection of UTI-associated
E. coli strains, a less discriminatory approach is intended.
Our studies extend the role of LAMP to the rapid diagnosis
of such infections, using this less-biased approach. In addi-
tion to the advantages described here, there are some lim-
itations of the assay in its current format. This assay is suited
for qualitative but not quantitative information. Possibly,
semiquantitative assays can be developed where the time
required to develop a positive reaction could be used as a
surrogate for the starting copy number. Also, LAMP assays
do not provide antimicrobial susceptibility information and
since bacteria demonstrate increasing resistance to antimi-
crobial agents, this assay is more likely to be an adjunct
rather than a replacement for culture. Finally, in contrast to
culture, this assay detects only a single organism. However,
LAMP assays for other common bacterial pathogens, in-
cluding Staphylococcus spp., have recently been reported
(13); these assays may potentially be combined with this
assay to screen for common infections. Further studies in-
volving a larger number of patients and different specimens
are needed in order to evaluate the clinical utility of this
assay.
TABLE 1. Description of isolates of E. coli evaluated by LAMP
Sourcea Sampleno.
Phylogenic
group Antigen(s) Sample
b Syndrome LAMPpositive
Clinical C1 A O147 Urine Cystitis Yes
C2 A O8 Urine Pyelonephritis Yes
C3 A O25:K2:H2 Blood Urosepsis Yes
C4 A O74 Feces NAc Yes
C5 B1 O75 Urine Cystitis Yes
C6 B1 O149 Urine Pyelonephritis Yes
C7 B1 O64:H21 Blood Urosepsis Yes
C8 B1 O86 Feces NA Yes
C9 B2 O6 Urine Cystitis Yes
C10 B2 ON Urine Cystitis Yes
C11 B2 O2 Urine Pyelonephritis Yes
C12 B2 O2 Urine Pyelonephritis Yes
C13 B2 O1:K1:H7 Blood Urosepsis Yes
C14 B2 O6:K2:H1 Blood Urosepsis Yes
C15 B2 ON Blood Abdominal
sepsis
Yes
C16 B2 O1 Blood Abdominal
sepsis
Yes
C17 B2 O1 Blood Pulmonary
sepsis
Yes
C18 B2 O1 Blood Pulmonary
sepsis
Yes
C19 B2 O6 Feces NA Yes
C20 B2 ON Feces NA Yes
C21 D O17,77 Urine Pyelonephritis Yes
C22 D O7:K1:H Blood Urosepsis Yes
C23 D O21 Feces NA Yes
ECOR ECOR-11 A O6 Urine Cystitis Yes
ECOR-5 A O79 Feces NA Yes
ECOR-3 A O1 Feces NA Yes
ECOR-72 B1 O144 Urine Pyelonephritis Yes
ECOR-28 B1 O104 Feces NA Yes
ECOR-33 B1 O79 Feces NA Yes
ECOR-45 B1 ON Feces NA Yes
ECOR-55 B2 O25 Urine Pyelonephritis Yes
ECOR-61 B2 O25 Feces NA Yes
ECOR-57 B2 ON Feces NA Yes
ECOR-48 D ON Urine Cystitis Yes
ECOR-39 D O79 Feces NA Yes
ECOR-37 E ON Feces NA Yes
a The clinical samples (C1 to C23) were collected at the Veterans Affairs
Medical Center, Minneapolis, MN.
b Feces isolates were from an uninfected, asymptomatic host.
c NA, not applicable.
TABLE 2. Clinical comparison of LAMP and culture results from
urine samples obtained from patients with suspected UTI
Culture result
No. of samples:
Tested Positive byLAMP
Negative by
LAMP
Positive for E. coli (pure culture and
100,000 CFU/ml)
22 22 0
No growth 36 0 36
Growth of bacteria other than E. coli,
including gram-positive, gram-
negative, fungus,
and multiple organisms
31 0 29
Gram positive (n  15)
Enterococcus faecalis 1 0 1
Lactobacillus spp. 1 0 1
Staphylococcus saprophyticus 1 0 1
Streptococcus spp. (alpha-hemolytic) 2 0 2
Streptococcus spp. (group B, beta-
hemolytic)
2 0 2
Gram-positive cocci (not otherwise
specified)
8 0 8
Gram negative (n  2)
Proteus mirabilis 1 0 1
Klebsiella oxytoca 1 0 1
Fungus (n  1)
Candida albicans 1 0 1
Multiple organisms (n  13) 13 2 11
Total 89 24 65
TABLE 3. Statistical comparison of LAMP and culture results from
urine samples obtained from patients with suspected UTIa
Comparison standard %Sensitivity
%
Specificity PPV NPV
LAMP vs culture 91.7 100 1.00 0.97
Culture vs LAMP 100 97 0.917 1.00
a PPV, positive predictive value; NPV, negative predictive value.
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